Epix Pharmaceuticals Inc. (formerly Predix Pharmaceuticals Inc.) was a pharmaceutical company based in Lexington, Massachusetts. Its products included the following agents:
PRX-00023—5-HT1A receptor full agonist (later discovered to be an antagonist): for major depression and generalized anxiety disorder PRX-03140—5-HT4 receptor partial agonist: for Alzheimer's disease PRX-07034—5-HT6 receptor antagonist: for obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia PRX-08066—5-HT2B receptor antagonist: for pulmonary hypertension associated with chronic obstructive pulmonary disease As of July 2009, the company was in the process of asset liquidation due to insufficient funds to stay afloat.
References
External links EPIX Pharmaceuticals, Inc. web site